KRONOS BIO INC (KRON)       3.38  +0.03 (+0.9%)

3.38  +0.03 (+0.9%)

US50107A1043 - Common Stock - After market: 3.38 0 (0%)

Buy % Consensus

Analysts have set a mean price target of 20.6. This target is 509.59% above the current price.
KRON was analyzed by 11 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about KRON.
In the previous month the buy percentage consensus was at a similar level.
KRON was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 3.3812.1215.3020.6037.80 - 258.58% 352.66% 509.59% 1,018.34%

Up and Down Grades

Date Firm Action Rating
2022-09-14 Berenberg Initiate Buy
2022-05-24 Goldman Sachs Maintains Buy
2022-05-23 Piper Sandler Maintains Overweight
2022-02-28 Piper Sandler Maintains Overweight
2021-11-10 HC Wainwright & Co. Maintains Buy
2021-06-24 HC Wainwright & Co. Initiate Buy

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA